The Beachbody Company, Inc.
NYSE:BODY
8.14 (USD) • At close March 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 119.01 | 128.25 | 134.948 | 144.901 | 148.166 | 165.975 | 179.136 | 198.922 | 216.266 | 208.052 | 223.108 | 226.219 | 224.283 | 251.479 | 218.484 | 169.336 |
| Cost of Revenue
| 45.038 | 53.219 | 52.204 | 53.561 | 63.545 | 61.309 | 91.867 | 105.905 | 118.708 | 73.067 | 68.77 | 68.117 | 70.546 | 70.925 | 59.389 | 48.847 |
| Gross Profit
| 73.972 | 75.031 | 82.744 | 91.34 | 84.621 | 104.666 | 87.269 | 93.017 | 97.558 | 134.985 | 154.338 | 158.102 | 153.737 | 180.554 | 159.095 | 120.489 |
| Gross Profit Ratio
| 0.622 | 0.585 | 0.613 | 0.63 | 0.571 | 0.631 | 0.487 | 0.468 | 0.451 | 0.649 | 0.692 | 0.699 | 0.685 | 0.718 | 0.728 | 0.712 |
| Reseach & Development Expenses
| 17.782 | 18.879 | 18.65 | 19.096 | 20.847 | 25.686 | 24.133 | 33.697 | 36.197 | 29.68 | 26.949 | 27.089 | 25.478 | 23.852 | 22.373 | 21.333 |
| General & Administrative Expenses
| 13.57 | 14.759 | 11.887 | 17.716 | 19.237 | 19.532 | 19.584 | 20.073 | 21.159 | 23.346 | 17.231 | 17.946 | 18.589 | 16.523 | 14.522 | 15.184 |
| Selling & Marketing Expenses
| 59.952 | 69.127 | 76.492 | 76.576 | 73.774 | 93.145 | 86.624 | 106.444 | 109.458 | 153.782 | 140.194 | 144.696 | 111.128 | 123.98 | 134.666 | 94.226 |
| SG&A
| 73.522 | 83.886 | 88.379 | 94.292 | 93.011 | 112.677 | 106.208 | 126.517 | 130.617 | 177.128 | 157.425 | 162.642 | 129.717 | 140.503 | 149.188 | 109.41 |
| Other Expenses
| -1.551 | 0.571 | 0.411 | 0.569 | 0.262 | 0.571 | 0.189 | -0.064 | 0.049 | 0.202 | 1.654 | 1.299 | 0.111 | 0.113 | 0.034 | 0.408 |
| Operating Expenses
| 91.304 | 102.765 | 107.029 | 113.388 | 113.858 | 138.363 | 130.341 | 160.214 | 166.814 | 206.808 | 184.374 | 189.731 | 155.195 | 164.355 | 171.561 | 130.743 |
| Operating Income
| -16.169 | -29.004 | -24.178 | -22.048 | -29.237 | -33.697 | -43.072 | -67.197 | -163.83 | -71.823 | -30.036 | -31.629 | -1.458 | 17.876 | -12.466 | -10.254 |
| Operating Income Ratio
| -0.136 | -0.226 | -0.179 | -0.152 | -0.197 | -0.203 | -0.24 | -0.338 | -0.758 | -0.345 | -0.135 | -0.14 | -0.007 | 0.071 | -0.057 | -0.061 |
| Total Other Income Expenses Net
| -48.932 | -4.869 | -1.582 | -7.092 | -11.113 | -0.711 | 0.924 | -7.042 | 15.068 | 30.414 | 6.739 | 0.543 | 0.016 | 1.701 | -0.214 | 0.313 |
| Income Before Tax
| -65.101 | -32.603 | -25.76 | -29.14 | -46.45 | -34.408 | -42.148 | -74.239 | -148.762 | -41.409 | -23.297 | -30.453 | -1.442 | 17.9 | -12.68 | -9.941 |
| Income Before Tax Ratio
| -0.547 | -0.254 | -0.191 | -0.201 | -0.313 | -0.207 | -0.235 | -0.373 | -0.688 | -0.199 | -0.104 | -0.135 | -0.006 | 0.071 | -0.058 | -0.059 |
| Income Tax Expense
| -0.136 | 0.063 | -0.012 | 0.048 | -1.517 | -0.549 | -0.281 | -0.706 | -2.8 | -1.487 | -10.857 | -0.395 | 15.43 | 4.129 | -2.677 | -1.613 |
| Net Income
| -65.039 | -32.666 | -25.748 | -29.188 | -44.933 | -33.859 | -41.867 | -73.533 | -145.962 | -39.922 | -12.44 | -30.058 | -16.872 | 13.771 | -10.003 | -8.328 |
| Net Income Ratio
| -0.547 | -0.255 | -0.191 | -0.201 | -0.303 | -0.204 | -0.234 | -0.37 | -0.675 | -0.192 | -0.056 | -0.133 | -0.075 | 0.055 | -0.046 | -0.049 |
| EPS
| -10.42 | -0.11 | -0.082 | -0.094 | -0.15 | -0.11 | -0.14 | -0.24 | -0.48 | -0.13 | -0.05 | -0.099 | -0.055 | 0.045 | -0.033 | -0.027 |
| EPS Diluted
| -10.42 | -0.11 | -0.082 | -0.094 | -0.15 | -0.11 | -0.14 | -0.24 | -0.48 | -0.13 | -0.05 | -0.099 | -0.055 | 0.045 | -0.033 | -0.027 |
| EBITDA
| 14.797 | -17.4 | -12.955 | -10.766 | -7.576 | -10.959 | -22.918 | -45.674 | -169.275 | -53.189 | -14.716 | -16.604 | 11.029 | 29.309 | -1.898 | 1.371 |
| EBITDA Ratio
| -0.994 | -0.136 | -0.096 | -0.036 | -0.196 | -0.095 | -0.128 | -0.23 | -0.32 | -0.274 | -0.072 | -0.073 | 0.049 | 0.109 | -0.009 | 0.002 |